Zürcher Kantonalbank Share Price

Certificat

RSSANZ

CH1218249592

Market Closed - Swiss Exchange 16:20:00 01/07/2024 BST
101.7 EUR +0.09% Intraday chart for Zürcher Kantonalbank
Current month+0.09%
1 month+0.39%
Date Price Change
01/07/24 101.7 +0.09%
28/06/24 101.6 +0.03%
25/06/24 101.6 +0.04%

Delayed Quote Swiss Exchange

Last update July 01, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying SANOFI
Issuer ZKB
RSSANZ
ISINCH1218249592
Date issued 04/03/2024
Strike 69.93
Maturity 02/09/2024 (60 Days)
Parity 0 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 101.7
Lowest since issue 100
Spread 500
Spread %0.49%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
91 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.78%
Consensus
  1. Stock Market
  2. Certificates
  3. RSSANZ Certificat